Karpova Y - Search Results

1

PARG suppresses tumorigenesis and downregulates genes controlling angiogenesis, inflammatory response, and immune cell recruitment.

Johnson S, Karpova Y, Guo D, Ghatak A, Markov DA, Tulin AV. Johnson S, et al. Among authors: karpova y. BMC Cancer. 2022 May 18;22(1):557. doi: 10.1186/s12885-022-09651-9. BMC Cancer. 2022. PMID: 35585513 Free PMC article.

2

Non-NAD-like PARP-1 inhibitors in prostate cancer treatment.

Karpova Y, Wu C, Divan A, McDonnell ME, Hewlett E, Makhov P, Gordon J, Ye M, Reitz AB, Childers WE, Skorski T, Kolenko V, Tulin AV. Karpova Y, et al. Biochem Pharmacol. 2019 Sep;167:149-162. doi: 10.1016/j.bcp.2019.03.021. Epub 2019 Mar 15. Biochem Pharmacol. 2019. PMID: 30880062 Free PMC article.

3

Poly(ADP)-Ribosylation Inhibition: A Promising Approach for Clear Cell Renal Cell Carcinoma Therapy.

Karpova Y, Guo D, Makhov P, Haines AM, Markov DA, Kolenko V, Tulin AV. Karpova Y, et al. Cancers (Basel). 2021 Oct 3;13(19):4973. doi: 10.3390/cancers13194973. Cancers (Basel). 2021. PMID: 34638458 Free PMC article.

4

Upregulation of PARG in prostate cancer cells suppresses their malignant behavior and downregulates tumor-promoting genes.

Karpova Y, Johnson SJ, Bordet G, Guo D, Ghatak A, Markov DA, Tulin AV. Karpova Y, et al. Biomed Pharmacother. 2022 Sep;153:113504. doi: 10.1016/j.biopha.2022.113504. Epub 2022 Aug 1. Biomed Pharmacother. 2022. PMID: 36076593 Free article.

5

Generating PARP Knockout D. melanogaster with CRISPR/Cas9 System.

Karpova Y, Tulin AV. Karpova Y, et al. Methods Mol Biol. 2023;2609:353-362. doi: 10.1007/978-1-0716-2891-1_21. Methods Mol Biol. 2023. PMID: 36515846

6

TaqMan Multiplex qPCR Method to Genotype PARG Knockout Mice.

Karpova Y, Tulin AV. Karpova Y, et al. Methods Mol Biol. 2023;2609:363-371. doi: 10.1007/978-1-0716-2891-1_22. Methods Mol Biol. 2023. PMID: 36515847

7

Cell-Based Screening for New PARP Inhibitors Utilizing PARG-Mutated Mouse Embryonic Stem Cells.

Karpova Y, Guo D, Tulin AV. Karpova Y, et al. Methods Mol Biol. 2023;2609:375-385. doi: 10.1007/978-1-0716-2891-1_23. Methods Mol Biol. 2023. PMID: 36515848

8

Disrupting Poly(ADP-ribosyl)ating Pathway Creates Premalignant Conditions in Mammalian Liver.

Karpova Y, Orlicky DJ, Schmidt EE, Tulin AV. Karpova Y, et al. Int J Mol Sci. 2023 Dec 6;24(24):17205. doi: 10.3390/ijms242417205. Int J Mol Sci. 2023. PMID: 38139034 Free PMC article.

9

Adaptive genetic mechanisms in mammalian Parp1 locus.

Karpova Y, Tulin AV. Karpova Y, et al. G3 (Bethesda). 2024 Sep 4;14(9):jkae165. doi: 10.1093/g3journal/jkae165. G3 (Bethesda). 2024. PMID: 39056235 Free PMC article.

10

Proteasomes in Patient Rectal Cancer and Different Intestine Locations: Where Does Proteasome Pool Change?

Erokhov PA, Kulikov AM, Karpova YD, Rodoman GV, Sumedi IR, Goncharov AL, Razbirin DV, Gorelova VS, Sharova NP, Astakhova TM. Erokhov PA, et al. Cancers (Basel). 2021 Mar 5;13(5):1108. doi: 10.3390/cancers13051108. Cancers (Basel). 2021. PMID: 33807574 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters